Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

FLT4 Antikörper (Extracellular Domain) (Biotin)

Der Maus Monoklonal Anti-FLT4-Antikörper wurde für WB und EIA validiert. Er ist geeignet, FLT4 in Proben von Human zu detektieren. Es ist 1 Publikation verfügbar.
Produktnummer ABIN115160

Kurzübersicht für FLT4 Antikörper (Extracellular Domain) (Biotin) (ABIN115160)

Target

Alle FLT4 Antikörper anzeigen
FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))

Reaktivität

  • 84
  • 55
  • 17
  • 12
Human

Wirt

  • 78
  • 28
  • 9
  • 2
  • 1
Maus

Klonalität

  • 79
  • 39
Monoklonal

Konjugat

  • 64
  • 11
  • 8
  • 6
  • 5
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser FLT4 Antikörper ist konjugiert mit Biotin

Applikation

  • 62
  • 50
  • 42
  • 32
  • 19
  • 17
  • 14
  • 13
  • 13
  • 9
  • 7
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)

Klon

3C3
  • Bindungsspezifität

    • 16
    • 13
    • 7
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain

    Spezifität

    Detects Human VEGFR-3/FLT-4.

    Aufreinigung

    Affinity Chromatography on Protein G .

    Immunogen

    Purified recombinant human Vascular Endothelial Growth Factor Receptor 3 (rh VEGFR-3/FLT-4) extracellular domain.

    Isotyp

    IgG1
  • Applikationshinweise

    ELISA: 0.5-1.5 μg/mL in direct ELISA, allows detection of 0.25-0.5 ng/well. Western blot: 0.5-1 μg/mL, detection limit is approximately 5 ng/lane under reducingconditions.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Rekonstitution

    Restore in sterile water to a concentration of > 0.5 mg/mL.

    Buffer

    0.1 M Tris-Cl, 0.1 M NaCl, pH 7.4 containing BSA (50x) as stabilizer and 0.02 % Sodium Azide as preservative.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    The lyophilized IgG is stable at 2-8 °C for one month and for one year from despatch when kept at -20 °C. When reconstituted in sterile water to a concentration of > 0.5 mg/ml the antibody is stable for six weeks at 2-8 °C or at -20 °C for longer. Aliquot to

    Haltbarkeit

    12 months
  • Davids, Davids, Charlton, Ng, Chong, Laubscher, Dar, Hodge, Soong, Goh: "Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, Issue 26, pp. e97-100, (2009) (PubMed).

  • Target

    FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))

    Andere Bezeichnung

    VEGFR-3 / Flt-4

    Hintergrund

    VEGFR-3/FLT-4, belongs to the class III subfamily of receptor tyrosine kinases. VEGFR-3/FLT-4 mediates the angiogenic activity of VEGF-C and VEGF-D on lymphatic endothelial cells.Synonyms: FLT4, Tyrosine-protein kinase receptor FLT4, VEGF Receptor 3, VEGFR3, Vascular endothelial growth factor receptor 3

    Gen-ID

    2324

    NCBI Accession

    NP_002011

    UniProt

    P35916

    Pathways

    RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Sie sind hier:
Chat with us!